Evidence map›Paper›PMID 25499255›Full record

ArticleJournal of experimental & clinical cancer research : CR2014

Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.

Rui Du, Shanshan Wu, Xiaoning Lv, Henghu Fang, Sudong Wu, Jingbo Kang

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rui DuDepartment of Radiation Oncology and Integrative Oncology, Navy General Hospital, 6# Fu Cheng Road, Beijing, 100037, People's Republic of China. durui1979@aliyun.com.
Shanshan WuDepartment of Radiation Oncology and Integrative Oncology, Navy General Hospital, 6# Fu Cheng Road, Beijing, 100037, People's Republic of China. Wushanshan0508@163.com.
Xiaoning LvDepartment of Aviation and Diving, Navy General Hospital, Beijing, People's Republic of China. Lvxiaoning1@sina.com.
Henghu FangDepartment of Radiation Oncology and Integrative Oncology, Navy General Hospital, 6# Fu Cheng Road, Beijing, 100037, People's Republic of China. 1339188824@163.com.
Sudong WuDepartment of Radiation Oncology and Integrative Oncology, Navy General Hospital, 6# Fu Cheng Road, Beijing, 100037, People's Republic of China. wusudong50@sina.com.
Jingbo KangDepartment of Radiation Oncology and Integrative Oncology, Navy General Hospital, 6# Fu Cheng Road, Beijing, 100037, People's Republic of China. Kjbnet@126.com.
PLA Navy General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsBrachyury overexpression has been reported in various human malignant neoplasms, but its expression and function in hepatocellular carcinoma progression and metastasis remains unknown. The present study aimed to evaluate the critical role of Brachyury in HCC metastasis.

methodsThe expression of Brachyury in human HCC (SMMC7721, HepG2, FHCC98, and Hep3B) and control cell lines was analyzed using quantitative reverse-transcriptase polymerase chain reaction and immunoflourence methods. Cancerous tissues collected from patients with HCC (n = 112) were analyzed using immunohistochemical method; a microarray analysis of HCC tissues was performed to explore the clinicopathological variables of HCC. The migratory and invasive capacities of Brachyury-SMMC7721 and Brachyury-HepG2 transfected cells were evaluated using in vitro scratch wound healing and Matrigel invasion assays, respectively. Further, six-week-old male BALB/c nude mice (n = 10) model was used in vivo assay.

resultsElevated expression of Brachyury was detected in HCCs (62.5%) compared with that in adjacent nontumorous tissues. Clinicopathological analysis revealed a close correlation of Brachyury expression with distant metastasis and poor prognosis of HCC. Overexpression of Brachyury promoted epithelial-mesenchymal transition (EMT) and metastasis of HCC cells in vitro and in vivo. Brachyury overexpression enhanced Akt activation by inhibiting phosphatase and tensin homolog (PTEN), which led to subsequent stabilization of Snail, a critical EMT mediator.

conclusionThe study findings suggest that elevated Brachyury facilitates HCC metastasis by promoting EMT via PTEN/Akt/Snail-dependent pathway. Brachyury plays a pivotal role in HCC metastasis and may serve as a novel prognostic biomarker and therapeutic target.

Indexed as

Epithelial-Mesenchymal TransitionAdultAgedAnimalsBrachyury ProteinCarcinoma, HepatocellularCase-Control StudiesCell MovementEnzyme ActivationFemaleFetal ProteinsGene Expression Regulation, NeoplasticHep G2 CellsHumansKaplan-Meier EstimateLiver NeoplasmsBrachyury ProteinFetal ProteinsProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanSnail Family Transcription FactorsT-Box Domain ProteinsTranscription Factors

Identifiers

PMID25499255
PMCPMC4279691
OpenAlexW1973512689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.